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Progesterone is indispensable for differentiation of human
endometrial stromal cells (HESCs) into decidual cells, a pro-
cess that critically controls embryo implantation. We now
show an important role for androgen receptor (AR) signal-
ing in this differentiation process. Decreased posttransla-
tional modification of the AR by small ubiquitin-like modifier
(SUMO)-1 in decidualizing cells accounted for increased
responsiveness to androgen. By combining small interfer-
ing RNA technology with genome-wide expression profil-
ing, we found that AR and progesterone receptor (PR) reg-
ulate the expression of distinct decidual gene networks.
Ingenuity pathway analysis implicated a preponderance of
AR-induced genes in cytoskeletal organization and cell mo-
tility, whereas analysis of AR-repressed genes suggested
involvement in cell cycle regulation. Functionally, AR de-
pletion prevented differentiation-dependent stress fiber
formation and promoted motility and proliferation of de-
cidualizing cells. In comparison, PR depletion perturbed
the expression of many more genes, underscoring the im-
portance of this nuclear receptor in diverse cellular func-
tions. However, several PR-dependent genes encode for sig-
naling intermediates, and knockdown of PR, but not AR,
compromised activation of WNT/-catenin, TGF/SMAD,
and signal transducer and activator of transcription (STAT)
pathways in decidualizing cells. Thus, the nonredundant
function of the AR in decidualizing HESCs, centered on
cytoskeletal organization and cell cycle regulation, implies
an important role for androgens in modulating fetal-mater-
nal interactions. Moreover, we show that PR regulates
HESC differentiation, at least in part, by reprogramming
growth factor and cytokine signal transduction. (Endocri-
nology 149: 4462–4474, 2008)
PROGESTERONE IS A pleiotropic hormone that reg-ulates all aspects of female reproduction, from ovu-
lation and embryo implantation to parturition. The actions
of progesterone (P4) on reproductive target tissues are
mediated predominantly by its cognate nuclear receptors,
P4 receptor (PR)-A and PR-B, members of the superfamily
of ligand-dependent transcription factors. In the uterus,
the postovulatory rise in P4 levels induces differentiation
of the endometrial mucosa in preparation for pregnancy
(1). A cardinal event in this remodeling process is the
transformation of endometrial stromal fibroblast into se-
cretory, epithelioid-like decidual cells (2–4). In addition to
the morphological changes, decidualization bestows some
unique functional properties on human endometrial stro-
mal cells (HESCs), including the ability to modulate local
immune cells, to resist environmental stress signals, and
to modulate trophoblast invasion (2–4). Mice deficient in
PR fail to mount a decidual response and are sterile (1).
However, activation of PR is in itself insufficient to induce
decidualization in mice or humans. Initiation of HESC
differentiation is strictly dependent upon elevated cAMP
levels and sustained activation of the protein kinase A
pathway, which in turn sensitize the cells to P4 (5, 6). Once
decidualized, the endometrium becomes inextricably de-
pendent upon continuous P4 signaling for homeostasis,
and in the absence of pregnancy, falling P4 levels trigger
a cascade of events that results in apoptosis, proteolytic
breakdown of the superficial endometrium, focal bleed-
ing, and menstrual shedding (7).
HESCs also abundantly express the androgen receptor
(AR) (8, 9), yet little is known about the function of this
nuclear receptor family member in the decidual process. AR
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and PR are phylogenetically closely related and share 54 and
80% sequence homology in their ligand- and DNA-binding
domains, respectively (10). AR expression, which is confined
to the stroma in cycling endometrium, decreases during the
secretory phase, although the receptor remains detectable in
the decidua of early pregnancy (11, 12). Serum androgen
levels fluctuate throughout the menstrual cycle, with levels
peaking around ovulation (13, 14). However, tissue andro-
gen levels and conversion of androstenedione to testosterone
are higher in secretory than proliferative endometrium (15).
Moreover, a rise in circulating androgen levels in the late
luteal phase is associated with a conception cycle and levels
continue to rise in early pregnancy (16). Interestingly, both
lack and excess of circulating androgens in premature ovar-
ian failure and polycystic ovary syndrome, respectively, are
associated with increased risk of early fetal loss and late
obstetric complication due to impaired placental function,
such as preeclampsia (17–19).
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FIG. 1. DHT selectively enhances decidual PRL expression in a time-dependent manner. A, Primary HESCs were cultured in the presence of
8-br-cAMP, P4, and DHT as indicated. The medium was collected and cells harvested every 48 h. The data represent the mean PRL (upper
panel) and IGFBP-1 (lower panel) concentrations (SD) in the supernatant, with normalization for RNA content at each time point, of triplicate
cultures. Significant differences were found in terms of PRL secretion between cultures treated with cAMP/P4 and cAMP/P4/DHT at 4, 6, and
8 d (*, P  0.05). B, Primary HESCs were decidualized with 8-Br-cAMP, P4, and increasing concentrations of DHT (0.001, 0.01, 0.1, and 1 M).
The medium was collected and assayed for PRL concentration. The data are expressed as percentage increase over cAMPP4 alone
(mean SD). C, RTQ-PCR analysis was carried out for PRL mRNA levels in cultures treated as in A. The results show mean PRL mRNA levels
(SD) normalized to L19 mRNA of three independent cultures. D, HESCs were treated as in A for 48 h followed by transfection with
dPRL-3000/Luc. Subsequently, the cells were maintained in the same culture conditions for 24 h. Luciferase and galactosidase assays were
performed, and the results represent the mean (SD) of triplicate measurements of one representative experiment. E, Primary HESCs were
cultured in the presence of 8-br-cAMP, P4, DHT, and bicalutamide (Casodex; CDX) as indicated and PRL secretion determined as described
above. PRL secretion was significantly different between cAMP/P4/DHT- and cAMP/P4/DHT/CDX-treated cultures (*, P  0.05). F, HESCs,
decidualized with a combination of 8-Br-cAMP, P4, and DHT for 48 h, were either mock-transfected or transfected with NT or AR siRNAs. The
treatments were continued for 72 h and the supernatants assayed for PRL. The data represent the relative effect of DHT (percent) on decidual
PRL secretion (mean  SD) of triplicate cultures normalized to total protein content of each well (*, P  0.01).
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These observations provide compelling but circumstantial
evidence that androgens play a role in decidual-trophoblast
interactions in pregnancy.We now demonstrate that decidu-
alization of HESCs is associated with increased responsive-
ness to androgen signaling. Compared with PR, AR controls
a much smaller but focused network of genes essential for
cytoskeletal organization and cell cycle regulation in decidu-
alizing endometrium.
Materials and Methods
Primary endometrial cell culture
The Local Research andEthics Committee atHammersmithHospitals
NHS Trust approved the study, and patient consentwas obtained before
tissue collection. HESC cultures were established as previously de-
scribed (2). Cultures were decidualized with 0.5 mm 8-Br-cAMP (Sigma
Chemical Co., St. Louis, MO) and medroxyprogesterone acetate (MPA;
Sigma), P4 (Sigma), dihydrotestosterone (DHT; Sigma), or bicalutamide
(Casodex; AstraZeneca, London, UK), all at 1 m bar for DHT, which
was used at 0.1 m concentration unless stated otherwise.
Transfections
Primary HESCs were transfected with DNA vectors or small inter-
fering RNA (siRNA) by the calcium phosphate coprecipitation method
using the Profection mammalian transfection kit (Promega, Madison,
WI), as previously described (2). All transfections were performed in
triplicate in 24-well plates and repeated at least three times. The ex-
pression plasmids for AR, PR-B, PIAS1, PIAS1(C351S, W372A), and
EGFP-SUMO1 have been described (2, 6). The reporter constructs
dPRL3000/Luc and PRE2/-32dPRL/Luc were a gift from B. Gellersen
(Endokrinologikum Hamburg, Hamburg, Germany) The concentration
of reporter constructs and expression vectors was 400 and 100 ng/well,
respectively. The control vector pCH110 (50 ng/well), which leads to
constitutive -galactosidase expression, was used to compare transfec-
tion efficiency. For gene silencing studies, HESCs were cultured in
six-well plates until confluency and transiently transfected with 100 nm of
the following siRNA reagents (Dharmacon, Lafayette, CO): siCONTROL
nontargeting (NT) siRNA Pool, AR siGENOME SMARTpool siRNA, PR
siGENOME SMARTpool siRNA, and PIAS1 siGENOME SMARTpool
siRNA.
Western blot analysis and prolactin (PRL) and insulin-like
growth factor-binding protein-1 (IGFBP-1) assays
Whole-cell lysates and nuclear protein fractions were obtained as
described elsewhere (4, 6). Proteins (30 g) were separated on a 10%
SDS-polyacrylamide gel before electrotransfer onto nitrocellulose mem-
brane (Amersham, Little Chalfont, UK). The following primary anti-
bodies were used: monoclonal AR (Biogenix, San Ramon, CA), mouse
monoclonal PR (Novocastra Laboratories, Newcastle-Upon-Tyne, UK),
mouse monoclonal -actin (Abcam, Cambridge, UK), rabbit total and
phosphorylated (Ser473) AKT (Cell Signaling, Hitchin, UK), rabbit total
and phosphorylated (Thr202/204) ERK1/2 (Cell Signaling), mouse -cate-
nin (Santa Cruz Biotechnology, Santa Cruz, CA), rabbit phosphorylated
(Ser807/811) pRB (Cell Signaling), rabbit phosphorylated MLC (Ser19)
(Cell Signaling), rabbit IL1R1 (Abcam), and rabbit signal transducer and
activator of transcription 3 (STAT3) and STAT5b (Upstate Biotechnol-
ogy, Lake Placid, NY). Primary antibodies were diluted to 1:1000 except
-actin, which was used at 1:100,000. Secondary antibodies were diluted
at 1:2000 dilution and protein complexes visualized with a chemolu-
minescent detection kit (Amersham). PRL in the HESC culture media
was measured by microparticle enzyme immunoassay (AxSYM system;
Abbott Laboratories,NorthChicago, IL). IGFBP-1 levels in culturemedia
were determined using an amplified two-step sandwich-type immuno-
assay (R&D Systems, Minneapolis, MN).
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FIG. 2. PIAS1 attenuates AR sumoylation and regulates endogenous androgen responses in differentiating HESCs. A, DHT antagonizes
AR down-regulation in decidualizing HESCs. Primary cultures were treated with a combination of 8-Br-cAMP, P4, DHT, and MPA, as
indicated. Whole-cell lysates, extracted every 48 h for 8 d, were immunoprobed for AR expression. B, Primary cultures transfected with
AR and EGFP-SUMO-1 were treated with vehicle or decidualized with 8-Br-cAMP with or without P4 for 48 h and then pulsed with DHT,
as indicated. Total protein lysates were probed for AR expression. Single and double EGFP-SUMO-1-modified AR species are indicated.
-Actin served as a loading control. C, HESCs were transfected with AR, EGFP-Sumo-1, and either NT siRNA or siRNA targeting PIAS1.
Cells were left untreated for 2 d and then treated with DHT as indicated. D, Parallel cultures were treated with 8-Br-cAMP and DHT
for 48 h and then subsequently transfected with pSG5 or pSG5-PIAS1 (wt or mt) and were analyzed for PRLmRNA expression by RTQ-PCR
(lower panel) and immunoprobed for AR and PIAS1 (upper panel), as indicated. E, Undifferentiated HESCs were transfected with NT or
PIAS1 siRNAs and treated 2 d later with vehicle or DHT for 48 h. The results show mean (SD) PRL transcript levels normalized to L19
mRNA of three independent cultures.
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Microarray and real-time quantitative (RTQ)-PCR
Gene expression profiling was performed on four independent
primary cultures, established from proliferative-phase biopsies. Total
RNA was isolated from cultured HESCs using Stat-60 (Tel-Test,
Friendswood, TX). Genomic DNA was removed by deoxyribonucle-
ase treatment, and the quality of the RNA was evaluated using a
Bioanalyzer 2100 (Agilent Technologies Inc., Santa Clara, CA). All
subsequent steps were carried out at the Finnish DNA-Microarray
Centre using the Sentrix Human Illumina 6 V1 Expression BeadChips
(Illumina, San Diego, CA), which contains over 47,000 known genes,
gene candidates, and splice variants. Three hundred nanograms of
each RNA sample, with 260/280 and 28S/18S ratio of greater than 1.8,
was used to make double-stranded cDNA and then biotinylated
cRNA using the Illumina RNA TotalPrep Amplification Kit (Ambion
Inc., Austin, TX). Labeled cRNA was purified and hybridized to the
BeadChip at 55 C, for 17 h after the Illumina Whole-Genome Gene
Expression Protocol for BeadStation. Hybridized biotinylated cRNA
was detected with cyanine3-streptavidin (Amersham). Arrays were
scanned with the Illumina BeadArray Reader, which is a confocal-
type imaging system with about 0.8-m resolution and 532-nm laser
illumination. The normalization and statistical analyses of the mi-
croarrays were performed using the statistical software R package
limma (http://www.R-project.org). Genes of coefficient of variation
values higher than 0.8 were filtered out from the analysis in prepro-
cessing. The same software was used for single-gene analyses in-
cluding fold-change calculations. The normalized data were analyzed
by pair-wise comparisons to create a list of differentially expressed
genes. Because we have shown that HESCs decidualized for 72 h are
only modestly sensitive to androgen signaling, differentially ex-
pressed genes were defined by a lower boundary of a 99% confidence
interval of fold change greater than 1.2 as validated by Student’s t test
(P  0.01). To interpret the biological significance of differentially
expressed genes, a gene ontology analysis was conducted using In-
genuity Pathways Analysis (IPA, Ingenuity Systems, http://ww-
w.ingenuity.com). RTQ-PCR analysis was performed as previously
described (4). All measurements were performed in triplicate. Gene-
specific primer pairs were designed using the ABI Primer Express
software (supplemental Table 1, published as supplemental data on
The Endocrine Society’s Journals Online web site at http://
endo.endojournals.org).
Fluorescence microscopy, motility, and proliferation assays
Immunofluorescence analysis was performed on cells seeded onto
glass coverslips, fixed in 4% paraformaldehyde, permeabilized with
0.5% Triton, and stained with tetramethylrhodamine isothiocyanate-
labeled phalloidin (Chemicon, Temecula, CA) and counterstained with
4,6-diamidino-2-phenylindole. The number of cells with actin stress
fibers per 100 cells was determined by an independent assessor, blinded
to the treatment, in three independent experiments. Cell motility was
assessed by time-lapse microscopy using an inverted microscope with
amotorized stage. Imageswere captured every 15min over a 48-h period
using a Hamamatsu C4742-95 CCD camera, and the distance each cell
moved was analyzed using Image Pro Plus software (Media Cybernet-
ics, Silver Spring, MD). Triplicate experiments were performed, and at
least 15 cells per field of view, chosen randomly, were analyzed. Pro-
liferation was ascertained using CellTiter 96 Aqueous One Solution Cell
Proliferation Assay (Promega).
Results and Discussion
Increased androgen responses in decidualizing HESCs
Secretion of PRL and IGFBP-1 in response to cAMP and P4
signaling is the hallmark of decidual transformation of
HESCs (2). To test whether androgens modify this differen-
tiation process, primary HESC cultures were treated with
8-Br-cAMP, P4, andDHT, either alone or in combination over
a time course lasting 8 d. Treatment with P4 alone was
insufficient to trigger expression of either differentiation
marker (Fig. 1A). In contrast, 8-Br-cAMP rapidly increased
PRL and IGFBP-1 secretion, but expression declined after 4 d
of treatment. As expected (2), enhanced and sustained ex-
pression of both IGFBP-1 and PRL in long-term cultures
required both 8-Br-cAMP and P4 signaling. DHT also mod-
estly enhanced the expression of both marker proteins in
8-Br-cAMP-treated cultures, but in contrast to P4, DHT was
insufficient to sustain the decidual response in prolonged
culture. Interestingly, DHT markedly enhanced PRL but not
IGFBP-1 secretion in cultures treated with 8-Br-cAMP plus
P4. This androgen response in decidualizing cultures in-
creased inmagnitude over time in a dose-dependent manner
(Fig. 1B). RTQ-PCR analysis demonstrated that the changes
in PRL transcript levels mirrored those at the protein level
(Fig. 1C). In addition, transfection studies with dPRL3000/
Luc, a luciferase reporter construct coupled to 3 kb of the
decidua-specific PRL promoter region (20), revealed that the
pattern of PRL expression in response to cAMP, P4, andDHT
corresponded to promoter activation (Fig. 1D).
To determine whether AR mediates the effect of DHT on
PRL expression, primary cultures were first treated with
8-Br-cAMP plus P4 in the presence or absence of DHT and
the nonsteroidal pure AR antagonist bicalutamide. This an-
tiandrogen entirely negated the ability of DHT to enhance
PRL secretion (Fig. 1E). Next, we transfected primary cul-
tures, pretreated for 48 h with 8-Br-cAMP and P4 in the
presence or absence of DHT, with either NT siRNA or siRNA
targeting AR. Notably, AR depletion was very efficient (see
A
C
cAMP/MPA:
B
**
NT siRNA:
AR siRNA:
PR siRNA:
-
+
-
-
-
+
+
-
-
P
R
L/
L1
9 
 m
R
N
A
(fo
ld
 c
ha
ng
e)
0
50
100
150
200
250
300
63 29 831
AR siRNA
(92)
PR siRNA
(860)
AR
PR-B
PR-A
β-actin
S
R
/L
19
  m
R
N
A
(fo
ld
 c
ha
ng
e)
NT siRNA:
AR siRNA:
PR siRNA:
+ + +
+
+
+
-
--
-
-
-
0.0
0.2
0.4
0.6
0.8
1.0
AR PR
FIG. 3. AR and PR knockdown perturbs the expression of distinct
gene sets in decidualizing HESCs. A, Validation of AR and PR si-
lencing. The upper panel shows RTQ-PCR analysis of AR and PR
transcript levels in cells transfectedwithNT,AR, orPR siRNAsbefore
treatment with 8-Br-cAMP and MPA for 72 h. AR and PR mRNA
levels were normalized to that of L19 mRNA, and the results are the
mean (SEM) of four separate cultures measured in triplicate. The
results are fold change relative to transcript levels in undifferentiated
cells transfected with NT siRNA (dotted line). The lower panel shows
Western blot analysis of AR and PR expression in protein lysates from
parallel cultures. -Actin served as a loading control. B, RTQ-PCR
analysis of PRL transcript levels, normalized to L19 mRNA, in cells
first transfectedwithNT, AR, or PR siRNA followed by differentiation
with 8-Br-cAMP and MPA for 72 h. The results are fold induction of
PRL mRNA expression relative to the levels in undifferentiated cells
transfectedwithNT siRNA. *,P 0.01. C, Venn diagram showing the
number of differentially expressed genes in decidualizing cells upon
AR or PR knockdown.
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Fig. 3A) and abolished the ability of DHT to enhance PRL
secretion in cells differentiated with 8-Br-cAMP and P4 (Fig.
1F). Together, the results unequivocally demonstrate that
androgen actions in decidualizing HESCs are dependent
upon AR activation.
Decidualization decreases small ubiquitin-like modifier
(SUMO)-1 modification of the activated AR
We postulated that enhanced AR expression could ac-
count for the gradual increase in androgen sensitivity
upon HESC differentiation. However, treatment of pri-
mary cultures with 8-Br-cAMP alone resulted in rapid but
transient reduction in AR levels (Fig. 2A). Conversely, P4
had little effect on AR levels in short-term cultures but
down-regulated receptor levels after 6–8 d of treatment.
Combined 8-Br-cAMP plus P4 treatment resulted in a
rapid and sustained decrease in cellular AR levels. DHT
strongly increased AR levels in undifferentiated cells (Fig.
2A), as described in other cell systems (21), but only par-
tially antagonized the down-regulation of the receptor in
decidualizing cells. Thus, as reported for P4 (2), increased
sensitivity to androgens in HESCs is paradoxically asso-
ciated with decreasing receptor levels.
In the case of P4, increased responsiveness has been linked
to global changes in cellular sumoylation upon HESC dif-
ferentiation (6). More specifically, decidualization is charac-
terized by a gradual decline in the expression of the E3
SUMO ligase protein inhibitor of activated STAT1 (PIAS1),
resulting in attenuated ligand-dependent sumoylation of PR,
increased transcriptional activity, and enhanced receptor
turnover. PIAS1 also serves as an E3 ligase for AR (22). This
prompted an analysis of AR sumoylation in undifferentiated
and decidualizing HESCs. Untreated cultures and cells first
decidualized with 8-Br-cAMP or 8-Br-cAMP plus P4 for 48 h
were transfected with expression vectors encoding AR and
enhanced green fluorescent protein (EGFP)-tagged SUMO-1
and pulsed 24 h later with DHT. Immunoblotting of cell
lysates with an anti-AR antibody demonstrated the presence
of two slower migrating forms of AR in undifferentiated
cells, first apparent after 10 min DHT stimulation, which
represent SUMO-1 modification of the two known acceptor
sites (K386 and K520) in AR (Fig. 2B) (22). Compared with
undifferentiated HESCs, DHT-dependent sumoylation of
ARwas attenuated in cells treatedwith 8-br-cAMPandmuch
more so in cultures decidualized with 8-Br-cAMP plus P4.
Next, we confirmed in COS-1 cells that increasing expression
TABLE 1. Genes down-regulated upon AR knockdown
Gene symbol Gene name Fold change
AR AR (DHT receptor) 1.81
CUTL1 (37) Cut-like 1 CCAAT displacement protein (Drosophila) 1.49
WASPIP (38, 39) Wiskott-Aldrich syndrome protein interacting protein 1.48
DUSP3 Dual-specificity phosphatase 3 (vaccinia virus
phosphatase VH1-related)
1.46
LOC255065 LOC255065 1.45
IL1R1 (32, 40) IL-1 receptor type I 1.43
PFTK1 (41) PFTAIRE protein kinase 1 1.42
PLA2G4F Phospholipase A2, group IVF 1.37
FAM135A Family with sequence similarity 135, member A 1.35
ALEX2 (42) Armadillo repeat protein ALEX2 1.35
SDCCAG1 Serologically defined colon cancer antigen 1 1.35
GNPDA1 Glucosamine-6-phosphate deaminase 1 1.33
LPGAT1 Lysophosphatidylglycerol acyltransferase 1 1.33
WDSUB1 WD repeat, sterile -motif and U-box domain containing 1 1.32
CAST (43) Calpastatin 1.32
ZBTB1 Zinc finger and BTB domain containing 10 1.28
LOC286470 LOC286470 1.27
PLS3 (44) Plastin 3 (T isoform) 1.27
ARHGEF7 (45) -Guanine nucleotide exchange factor (GEF) 7 1.27
ACTR3 (46) ARP3 actin-related protein 3 homolog (yeast) 1.27
AMBRA1 (47) Autophagy/beclin-1 1.27
PB1 Polybromo 1 1.26
FLJ00060 Hypothetical gene FLJ00060 1.25
KLHDC5 Kelch domain containing 5 1.25
NR2F2 Nuclear receptor subfamily 2 group F member 2 1.25
WDR40A WD repeat domain 40A 1.23
GDI1 (48) GDP dissociation inhibitor 1 1.22
RPC8 RNA polymerase III subunit RPC8 1.22
C5orf24 Chromosome 5 open reading frame 24 1.22
WBSCR16 Williams-Beuren syndrome chromosome region 16 1.22
AHI1 Abelson helper integration site 1.21
FBXW1B F-box and WD-40 domain protein 1B 1.21
POMT2 (49) Protein-O-mannosyltransferase 2 1.21
SMTN (50) Smoothelin 1.21
MADHIP Mothers against decapentaplegic homolog (Drosophila) interacting protein 1.20
C19orf26 Chromosome 19 open reading frame 26 1.20
DYRK1A (51, 52) Dual-specificity tyrosine-(Y)-phosphorylation regulated
kinase 1A
1.20
Gene symbols in bold indicate genes known to be regulated in endometrium. Genes implicated in cytoskeletal organization are referenced.
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of PIAS1 enhances ligand-dependent AR sumoylation
(supplemental Fig. 1) and, conversely, that PIAS1 knock-
down reduces AR SUMO-1 modification in HESCs treated
with DHT (Fig. 2C). To explore whether PIAS1 regulates
endogenous androgen responses in HESCs, we first over-
expressed wild-type PIAS1 or a PIAS1 mutant (C351S,
W372A) devoid of E3-ligase activity in cells decidualized
with 8-Br-cAMP and DHT for 48 h. Parallel cultures were
harvested after 24 h for protein and mRNA analyses. As
shown in Fig. 2D, wild-type but not mutant PIAS1 en-
hanced SUMO-1 modification of AR, which corresponded
to a 50% decrease in PRL mRNA expression. Notably,
expression of the E3-deficient mutant antagonized endog-
enous PIAS1, resulting in decreased AR sumoylation and
higher PRL mRNA levels. Furthermore, PIAS1 knock-
down in undifferentiated HESCs was sufficient to induce
PRL expression in response to DHT without the need of
additional decidualizing stimuli (Fig. 2E). Together, the
results demonstrate that down-regulation of PIAS1 upon
decidualization sensitizes HESCs not only to P4 (6) but
also to androgen signaling.
Identification of decidual AR and PR target genes
MPA, a 17-OH P4 derivative with known androgenic
actions (23), is widely used in combination with 8-Br-
cAMP to differentiate HESCs in vitro (2, 20). We confirmed
thatMPA, like DHT but not P4, enhances cellular AR levels
in HESCs, induces its nuclear accumulation, and transac-
tivates the receptor in a reporter assay (supplemental
Fig. 2). We exploited the progestogenic and androgenic
properties of MPA to search for specific AR- and PR-
dependent genes in decidualizing HESCs. Four separate
primary cultures were first transfected with either NT
siRNA oligos or a siRNA pool targeting AR or PR and then
treated with 8-Br-cAMP plus MPA for 72 h. Parallel cul-
tures were harvested for mRNA and protein analysis. As
shown in Fig. 3A, the siRNA knockdown approach for AR
and PR was effective and selective at both the mRNA and
protein level. Furthermore, knockdown of either receptor
was equally efficient in attenuating PRLmRNA expression
in differentiating HESCs (Fig. 3B). Total RNA was then
processed for genome-wide expression profiling, and the
data were interrogated using parametric statistical testing.
Figure 3C represents the Venn diagram of regulated genes
identified by the following pair-wise comparisons: AR
siRNA-transfected cells (AR) vs. NT siRNA-transfected
cells and PR siRNA-transfected cells (PR) vs. NT siRNA-
transfected cells. AR knockdown affected the expression of
a relatively small pool of genes. Of the 92 transcripts
deregulated upon AR depletion, the expression of 42.4 and
57.6% of transcripts were up- and down-regulated, re-
spectively (Tables 1 and 2). In contrast, PR knockdown
perturbed the expression of 860 genes, 55.6% of which
were up-regulated and 44.4% down-regulated. Tables 3
and 4 list the 50 most induced and repressed PR-depen-
dent genes, respectively. We identified only 29 genes un-
der control of both nuclear receptors in decidualizing
cells, although 10 were regulated in an opposing manner
(Table 5). Thus, the data confirm the major role of PR in
regulating decidual gene expression and define, for the
first time, a smaller but distinct set of genes under AR
control.
TABLE 2. Genes up-regulated upon AR knockdown
Gene symbol Gene name Fold change
DIPA Hepatitis -antigen-interacting protein A 1.45
CADPS2 Ca2-dependent activator protein for secretion 2 1.41
UGP2 UDP-glucose pyrophosphorylase 2 1.39
MCM4 MCM4 minichromosome maintenance deficient 4
(S. cerevisiae)
1.37
OIP5 Opa-interacting protein 5 1.33
CDT1 DNA replication factor 1.33
POLR1D Polymerase (RNA) I polypeptide D 16 kDa 1.30
CCDC99 Coiled-coil domain containing 99 1.26
FDXR Ferredoxin reductase 1.26
TMEM160 Transmembrane protein 160 1.25
TBC1D13 TBC1 domain family member 13 1.25
C3orf26 Chromosome 3 open reading frame 26 1.25
NDFIP2 Nedd4 family interacting protein 2 1.25
ANKRD36 Ankyrin repeat domain 36 1.25
WDR51A WD repeat domain 51A 1.24
IQCC IQ motif containing C 1.23
MEIS2 Meis1 myeloid ecotropic viral integration site 1
homolog 2 (mouse)
1.22
LOC121642 Similar to prostate cancer antigen-1 1.22
ACAS2 Acetyl-coenzyme A synthetase 2 (AMP forming)-like 1.22
RGS10 Regulator of G-protein signaling 10 1.21
CHTF18 CTF18 chromosome transmission fidelity factor 18
homolog (S. cerevisiae)
1.21
PDE7B Phosphodiesterase 7B 1.20
RPL10A Ribosomal protein L10a 1.20
HBLD1 HESB like domain containing 1 1.20
ECE2 Endothelin converting enzyme 2 1.20
PRO0386 Hypothetical protein PRO0386 1.20
Gene symbols in bold indicate genes known to be regulated in endometrium.
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Because all cultures were decidualized before array anal-
ysis, we cross-referenced our genes lists with the Endome-
trium Database Resource (http://endometrium.bcm.tmc.
edu/edr/) and annotated the tables to indicate genes already
reported to be regulated upon endometrial differentiation.
RTQ-PCR validation of genes under the putative control of
AR (IL1R1, DUSP3, and OIP5), PR (MMP10, TWIST1, and
RASD1), or both AR and PR (KCNK3, PCDH7, and WNT4)
yielded no false-positive results (Fig. 4). Interestingly, not
all identified target genes were dependent upon ligand
activation of the receptor. For instance,DUSP3 (dual-spec-
ificity phosphatase 3) mRNA levels remained unchanged
upon HESC differentiation, yet transfection of AR siRNA
resulted in a 3-fold decrease in the transcript levels of this
negative regulator of the MAPK pathway. Similarly,
MMP10 (matrix metalloproteinase 10) expression was
strongly repressed in differentiating HESCs, and PR
knockdown not only reversed this repression but also
elicited a 4-fold increase in MMP10 mRNA levels when
compared with undifferentiated cells, suggesting that
even the unliganded PR plays a role in repressing MMP
expression in human endometrium.
TABLE 3. Top 50 down-regulated genes upon PR knockdown
Gene symbol Gene name Fold change
APCDD1 Adenomatosis polyposis coli down-regulated 1 5.37
CNR1 Cannabinoid receptor 1 4.21
LOC347348 Similar to heat-shock 27-kDa protein (HSP27) 3.34
CHST7 Carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7 3.19
HSPB1 Heat-shock 27-kDa protein 1 3.19
RASD1 RAS dexamethasone-induced 3.12
FKBP5 FK506 binding protein 5 3.10
IGF1 IGF-I (somatomedin C) 3.04
RORB RAR-related orphan receptor B 3.01
C13orf33 Chromosome 13 open reading frame 33 3.00
ACPL2 Acid phosphatase-like 2 2.71
SORBS1 Sorbin and SH3 domain containing 1 2.59
PCDH19 Protocadherin 19 2.59
HSD11B1 Hydroxysteroid (11-) dehydrogenase 1 2.56
AOX1 Aldehyde oxidase 1 2.51
PDLIM1 PDZ and LIM domain 1 (elfin) 2.51
RASL10B RAS-like family 10 member B 2.5
BTBD3 BTB (POZ) domain containing 3 2.46
MDM1 Nuclear protein double minute 1 2.46
ZNF145 Zinc finger protein 145 (Kruppel-like expressed in
promyelocytic leukemia)
2.41
ADAMTS1 A disintegrin-like and metalloprotease (reprolysin type)
with thrombospondin type 1 motif 1
2.41
IMPA2 Inositol(myo)-1(or 4)-monophosphatase 2 2.38
NRXN3 Neurexin 3 2.32
HSPB6 Heat-shock protein, -crystallin-related, B6 2.32
METTL7A Methyltransferase like 7A 2.28
OSR2 Odd-skipped-related 2A protein 2.27
SIPA1L2 Signal-induced proliferation-associated 1 like 2 2.25
DSIPI -Sleep inducing peptide immunoreactor 2.24
PRPS2 Phosphoribosyl pyrophosphate synthetase 2 2.21
GATA6 GATA binding protein 6 2.20
PPAP2B Phosphatidic acid phosphatase type 2B 2.20
PIK3R1 Phosphoinositide-3-kinase regulatory subunit polypeptide 1
(p85 )
2.16
SERPINE1 Serine (or cysteine) proteinase inhibitor clade E 2.15
XYLT1 Xylotransferase 1 2.14
ATAD2 ATPase family, AAA domain containing 2 2.13
TIPARP TCDD-inducible poly(ADP-ribose) polymerase 2.13
ABLIM3 Actin-binding LIM protein family member 3 2.12
CARD9 Caspase recruitment domain family member 9 2.12
LARGE Like-glycosyltransferas 2.09
NPR1 Natriuretic peptide receptor A/guanylate cyclase A 2.09
PGR Progesterone receptor 2.08
DKK1 Dickkopf homolog 1 (Xenopus laevis) 2.05
RAB40A RAB40A member RAS oncogene family 2.03
LMCD1 LIM and cysteine-rich domains 1 2.02
RACGAP1 Rac GTPase activating protein 1 2.00
SLC27A3 Solute carrier family 27 (fatty acid transporter) member 3 1.96
FLJ11539 Hypothetical protein FLJ11539 1.95
SLC7A8 Solute carrier family 7 (cationic amino acid transporter y
system) member 8
1.95
MYC v-myc myelocytomatosis viral oncogene homolog (avian) 1.94
TNFRSF1B TNF receptor superfamily member 1B 1.92
Gene symbols in bold indicate genes known to be regulated in endometrium.
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PR is indispensable for activation of secondary signaling
pathways upon decidualization
Microarray analyses have been extensively used to exam-
ine endometrial responses to P4 in humans and various an-
imal models (24–26). Our gene profiling complements these
studies and confirms that PR controls the expression of a
network of at least 860 genes in decidualizing HESCs. Inge-
nuity Pathway Analysis clustered PR-dependent genes into
28 different functional molecular and cellular categories
(supplemental Fig. 3), and many can be functionally linked
to known P4 actions in the endometrium. For instance, P4
critically ensures tissue integrity of the decidualizing endo-
metrium before menstruation and during pregnancy (3, 7),
and not unexpectedly, several genes repressed in a PR-de-
pendentmanner encode formatrixmetalloproteinases (MMP2,
-8, -10, -11, and -27), death receptors of the tumor necrosis
factor receptor superfamily (TNFRSF10B, -10D, -11B, -19, and
-21), apoptosis mediators (e.g. MCL1, NR4A2, BCL2L10,
TRAF4,TP53INP,MOAP1, SEMA3F,DAD1,CIAPN1,DEDD,
andMAP3K5), and oxidative stress defenses andDNA repair
(e.g. TXNRD1, HNOX1, PPP1R15A, and XRCC5).
Although insufficient to trigger HESC differentiation,
TABLE 4. Top 50 up-regulated genes upon PR knockdown
Gene symbol Gene name Fold change
CXCR4 Chemokine (C-X-C motif) receptor 4 6.69
MMP10 Matrix metalloproteinase 10 (stromelysin 2) 5.29
STC1 Stanniocalcin 1 5.20
KIAA1199 KIAA1199 protein 5.01
FJX1 Four jointed box 1 (Drosophila) 4.81
TNFRSF11B TNF receptor superfamily member 11b (osteoprotegerin) 3.99
ABCG1 ATP-binding cassette sub-family G (WHITE) member 1 3.76
MMP11 Matrix metalloproteinase 11 (stromelysin 3) 3.56
IER3 Immediate-early response 3 3.35
SLC16A6 Solute carrier family 16 (monocarboxylic acid transporters)
member 6
3.14
CDKN2B Cyclin-dependent kinase inhibitor 2B (p15 inhibits CDK4) 2.86
GDF15 Growth differentiation factor 15 2.76
IL13RA2 IL-13 receptor 2 2.75
ANGPTL2 Angiopoietin-like 2 2.74
THBS2 Thrombospondin 2 2.72
NR4A2 Nuclear receptor subfamily 4 group A member 2 2.63
C10orf10 Chromosome 10 open reading frame 10 2.63
SOX4 SRY (sex determining region Y)-box 4 2.56
FAM43A Family with sequence similarity 43, member A 2.53
TEK TEK tyrosine kinase endothelial 2.50
DPYSL4 Dihydropyrimidinase-like 4 2.48
NNAT Neuronatin 2.45
MEX3A Mex-3 homolog A 2.45
PDE4B Phosphodiesterase 4B cAMP-specific 2.41
FOXP1 Forkhead box P1 2.32
AMSH-LP Associated molecule with the SH3 domain of STAM (AMSH) like
protein
2.32
FRMD4 FERM domain containing 4 2.29
TWIST1 Twist homolog 1) 2.25
ARNT2 Aryl-hydrocarbon receptor nuclear translocator 2 2.24
CNIH3 Cornichon homolg 3 2.23
PPFIBP2 PTPRF interacting protein binding protein 2 (liprin  2) 2.22
LOH11CR2A Loss of heterozygosity11 chromosomal region 2 2.22
EHZF Early hematopoietic zinc finger 2.19
DIO2 Deiodinase iodothyronine type II 2.19
ABCA6 ATP-binding cassette sub-family A (ABC1) member 6 2.18
CXCL12 Chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) 2.18
TNFRSF21 TNF receptor member 21 2.16
FLJ22536 Hypothetical locus LOC401237 2.16
FHOD3 Formin homology 2 domain containing 3 2.15
WNT2 Wingless-type MMTV integration site family member 2 2.15
F13A1 Coagulation factor XIII A1 polypeptide 2.14
KIAA1370 Hypothetical protein LOC56204 2.14
CSRP2 Cysteine- and glycine-rich protein 2 2.07
CHAC1 ChaC, cation transport regulator homolog 1 2.06
CREB5 cAMP responsive element binding protein 5 2.06
PBEF1 Pre-B-cell colony enhancing factor 1 2.04
FGF9 Fibroblast growth factor 9 2.04
MGC13057 Hypothetical protein MGC13057 2.04
FAP Fibroblast activation protein  2.02
LOC221091 Hypothetical protein LOC221091 2.01
Gene symbols in bold indicate genes known to be regulated in endometrium.
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P4 is essential for maintaining the decidual phenotype
both in vivo and in vitro. Compelling evidence has emerged
to indicate that sustained expression of the decidual phe-
notype is also dependent on autocrine or paracrine signals,
resulting in activation of various secondary signaling
pathways (5, 27, 28). Strikingly, a significant number of
PR-dependent genes encode for ligands, membrane-
bound receptors, and intermediates in various signal trans-
duction pathways (supplemental Fig. 4). This prompted us to
examine the expression and/or activation status of critical
signal intermediates in the STAT, MAPK (ERK1/2), PI3K,
TGF/SMAD, and WNT/-catenin pathways in undiffer-
entiated HESCs and decidualized cells transfected with
AR or PR siRNAs. In agreement with the gene profile, PR
knockdown selectively abolished the induction of STAT3
and STAT5b upon HESC differentiation (Fig. 5). Total
ERK1/2, AKT, SMAD2, and -catenin levels remained
unchanged upon differentiation of HESCs. However, de-
cidualization was accompanied by a down-regulation in
activated (phosphorylated) AKT levels and a reciprocal
increase in ERK1/2 phosphorylation, yet the activation
status of either pathway was unaffected by AR or PR
depletion. In contrast, PR knockdown eliminated nuclear
accumulation of activated SMAD2 and -catenin in dif-
ferentiating HESCs. The data imply that a substantial pro-
portion of PR-dependent decidual genes are regulated
indirectly, via autocrine or paracrine activation of the
WNT/-catenin, TGF/SMAD, and STAT pathways.
AR regulates cytoskeletal organization and cell cycle
inhibition
Ingenuity pathway analysis complemented by manual
mining of available literature implicated 40% (21 of 53) of
genes down-regulated upon AR silencing in the regulation
of cell morphology, cytoskeletal organization, and cell
motility (Tables 1 and 5). This prompted us to examine
more closely the differentiation-associated changes in the
actin cytoskeleton by phalloidin staining of filamentous
actin (F-actin). As shown in Fig. 6A, decidualization is
characterized by a dramatic increase in F-actin polymer-
ization and stress fiber formation. However, the propor-
tion of cells that express elongated stress fibers was re-
duced by approximately 50% upon AR knockdown,
whereas PR silencing had no apparent effect (Fig. 6A and
supplemental Fig. 5). Time-lapse microscopy demon-
strated that decidualization is also associated with a dra-
matic decrease in basal cell motility, which was partially
reversed upon AR knockdown (Fig. 6B). Actin-myosin
interactions are essential for cell motility and promoted by
phosphorylation of the regulatory light chain of myosin 2
(MLC2) (29). In agreement with the motility studies, AR
knockdown was sufficient to reverse loss of MLC2 phos-
phorylation upon decidualization of HESCs (Fig. 6C).
In addition to cell motility, the actin cytoskeleton is in-
volved in many other biological functions, including endo-
and exocytosis, cytokinesis, and signal transduction (30, 31),
TABLE 5. Genes regulated by AR and PR
Gene symbol Gene name AR siRNA fold change PR siRNA fold change
INHBA Inhibin  A 1.56 2.38
KCNK3 Potassium channel subfamily K member 3 1.55 1.36
FADS2 Fatty acid desaturase 2 1.45 1.55
LMOD1 (53) Leiomodin 1 (smooth muscle) 1.43 1.67
WNT4 Wingless-type MMTV integration site family member 4 1.39 1.60
ELOVL4 Elongation of very long chain fatty acids (FEN1/Elo2
SUR4/Elo3 yeast)-like 4
1.36 1.40
GPR125 (54) G protein-coupled receptor 125 1.30 1.37
KIAA1377 KIAA1377 protein 1.27 1.28
LRRK1 (55) Leucine-rich repeat kinase 1 1.24 1.35
LRCH2 Leucine-rich repeats and calponin homology (CH)
domain containing 2
1.23 1.49
CTSO (56) Cathepsin O 1.21 1.23
CKAP4 (57) Cytoskeleton-associated protein 4 1.21 1.22
TEAD3 (58, 59) TEA domain family member 3 1.20 1.26
LOC401627 Similar to hypothetical protein FLJ33610 1.20 1.21
TCEAL7 Transcription elongation factor A (SII)-like 7 1.20 1.59
MRAS (60) Muscle RAS oncogene homolog 1.20 1.34
MCM2 MCM2 minichromosome maintenance deficient 2
mitotin (S. cerevisiae)
1.39 1.25
PCDH7 BH-protocadherin (brain-heart) 1.38 1.74
PCDH7 BH-protocadherin (brain-heart) 1.28 1.63
HNRPH2 Heterogeneous nuclear ribonucleoprotein H2 (H’) 1.27 1.23
WEE1 WEE1 homolog (S. pombe) 1.26 1.32
IMPDH2 IMP (inosine monophosphate) dehydrogenase 2 1.25 1.24
ACSL1 Acyl-CoA synthetase long-chain family member 1 1.23 1.43
DPP4 Dipeptidylpeptidase 4 (CD26 adenosine deaminase
complexing protein 2)
1.23 1.51
XTP3TPA XTP3-transactivated protein A 1.23 1.21
XAB1 XPA binding protein 1 1.22 1.43
PAK1 PAK1 interacting protein 1 1.22 1.35
BM88 BM88 antigen 1.20 1.28
NAP1L1 Nucleosome assembly protein 1-like 1 1.20 1.29
Gene symbols in bold indicate genes known to be regulated in endometrium. Genes implicated in cytoskeletal organization are referenced.
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underscoring the importance of AR in regulating decidual
cell function. Importantly, induction of the IL-1 receptor
(IL1R1) in decidualizing cells is under AR control (Fig. 4).
Embryonic signals, and in particular IL-1, have been shown
to activate focal adhesion kinase (FAK) and to further pro-
mote cytoskeletal reorganization in decidual cells (32). To-
gether, these observations suggest AR plays a major role in
coordinating decidual-trophoblast interactions during early
pregnancy. This conjecture is further supported by the ob-
servation that inactivation of decidual RhoA, a Rho GTPase
familymember essential for cytoskeletal organization, blocks
outgrowth but not attachment of blastocysts in a coculture
model (33).
In silico analysis further revealed that several genes up-
regulated in decidualizing cells uponAR depletion, and thus
normally repressed in an AR-dependent manner, are in-
volved in various aspects of cell cycle regulation (e.g.
NAP1L1, WEE1, BM88, XTP3TA, and IMPDH2) including
DNA replication licensing (e.g. CDT1, MCM4, and MCM2)
and chromatid separation (e.g. CHTF18, DIPA) (Tables 2 and
5). This expression profile points toward a role for AR in
safeguarding the genetic stability of the endometriumduring
rapid cyclic remodeling. Functionally, AR knockdown en-
hanced proliferation ofHESCs decidualizedwith 8-Br-cAMP
and MPA (Fig. 6D). In contrast, proliferation was modestly
but consistently reduced upon PR knockdown. Inactivation
of retinoblastoma protein (RB) by hyperphosphorylation en-
ables the expression of E2F-target genes essential for coor-
dinating entry into S phase of the cell cycle (34). As shown
in Fig. 6E, differentiation of HESCs is strongly associated
with loss of RB phosphorylation but much less so upon AR
knockdown.
In summary, we have shown that HESCs become in-
creasingly responsive to androgen signaling upon differ-
entiation. This increased sensitivity to sex steroids,
whether androgens or P4, is directly linked to global
changes in cellular sumoylation and, more specifically, to
differentiation-dependent down-regulation of PIAS1, the
E3 SUMO-1 ligase of AR and PR. In comparison to PR, AR
governs the expression of a limited decidual gene pool,
* *
*
0
2
4
6
8
NT siRNA:
AR siRNA:
PR siRNA:
-
+
-
-
-
+
+
-
-
IL
1R
1/
L1
9 
 m
R
N
A
(fo
ld
 c
ha
ng
e)
D
U
S
P
3/
L1
9 
 m
R
N
A
(fo
ld
 c
ha
ng
e)
0.0
0.2
0.4
0.6
0.8
1.0
O
IP
5/
L1
9 
 m
R
N
A
(fo
ld
 c
ha
ng
e)
A B C
*
0.0
0.2
0.4
0.6
0.8
1.0
1.2
*
*
0
5
10
15
20
25
K
C
N
K
3/
L1
9 
 m
R
N
A
(fo
ld
 c
ha
ng
e)
0.0
0.2
0.4
0.6
0.8
1.0
P
C
D
H
7/
L1
9 
 m
R
N
A
(fo
ld
 c
ha
ng
e)
G H I
*
**
W
N
T4
/L
19
  m
R
N
A
(fo
ld
 c
ha
ng
e)
0
100
200
300
400
500
600
* **
0
1
2
3
4
5
M
M
P
10
/L
19
  m
R
N
A
(fo
ld
 c
ha
ng
e)
0
0.2
0.4
0.6
0.8
1
1.2
TW
IS
T1
/L
19
  m
R
N
A
(fo
ld
 c
ha
ng
e)
D E F
0
10
20
30
40
50
60
70
NT siRNA:
AR siRNA:
PR siRNA:
-
+
-
-
-
+
+
-
-
NT siRNA:
AR siRNA:
PR siRNA:
-
+
-
-
-
+
+
-
-
NT siRNA:
AR siRNA:
PR siRNA:
-
+
-
-
-
+
+
-
-
NT siRNA:
AR siRNA:
PR siRNA:
-
+
-
-
-
+
+
-
-
NT siRNA:
AR siRNA:
PR siRNA:
-
+
-
-
-
+
+
-
-
NT siRNA:
AR siRNA:
PR siRNA:
-
+
-
-
-
+
+
-
-
NT siRNA:
AR siRNA:
PR siRNA:
-
+
-
-
-
+
+
-
-
NT siRNA:
AR siRNA:
PR siRNA:
-
+
-
-
-
+
+
-
-
R
A
S
D
1/
L1
9 
 m
R
N
A
(fo
ld
 c
ha
ng
e)
FIG. 4. Validation of putative AR- and
PR-dependent genes. For microarray val-
idation, three separate cultureswere first
transfected with NT, AR, or PR siRNA
and then treated with 8-Br-cAMP and
MPA for 72 h, and mRNA levels of the
indicated putative target genes were
measured in triplicate for each sample by
RTQ-PCR. The data normalized to L19
are expressed as fold change (SEM) rel-
ative to expression levels in undifferen-
tiatedHESCs transfectedwithNT siRNA
(dotted lines). *, P  0.05; **, P  0.001.
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responsible for cytoskeletal organization and inhibition of
cell motility and proliferation. These cell functions under
AR control may be critical for coordinated trophoblast
invasion and placental development. This notion is sup-
ported by the observations in female AR-deficient mice,
demonstrating that uterine responses to exogenous go-
nadotropins are impaired before developing premature
ovarian failure (35). Furthermore, the earliest reproductive
defect in these mice is a dramatic reduction in the number
of pups per litter, and pregnancy is further characterized
by placentamegaly, which suggests a compensatory re-
sponse to defective uterine remodeling (35, 36). However,
additional experiments are required to exclude the pos-
sibility that these early uterine defects in AR-deficient
mice are a consequence of impaired ovarian steroido-
genesis.
The identification of human AR signature genes could
be exploited to assess the decidual responses before preg-
nancy, especially in patients with relative androgen defi-
ciency, including older women and patients with prema-
ture ovarian failure receiving fertility treatment with
donor oocytes. Such translational studies may provide the
in vivo rational for the targeted use of selective AR mod-
ulators for the prevention of associated pregnancy compli-
cations.
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fection with NT siRNA (b), AR siRNA (c), or PR siRNA (d). B,
Motility of HESCs transfected and treated as in A was analyzed by
time-lapse microscopy, quantified, and expressed in arbitrary
units. The results are the mean (SD) of triplicate analyses. Dif-
ferent letters above the error bars indicate that those groups are
significantly different from each other at P  0.01. C, Protein
lysates obtained from parallel cultures were immunoprobed for
phosphorylated MLC2. -Actin served as a loading control. D,
Primary cultures were first transfected in six-well plates with NT,
AR, or PR siRNAs, replated in 96-well plates, and treated with
8-Br-cAMP and MPA, and cell viability was measured at the in-
dicated time points. The results show the relative fold change in
cell number, and the data are the mean (SD) of triplicate mea-
surements. E, Protein lysates from HESCs transfected with NT,
AR, or PR siRNA, then treated with 8-Br-cAMP and MPA for 72 h,
were subjected to Western blot analysis for total and phosphory-
lated RB (p-RB) expression.
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